Home > Cashflow Statement > ORCHID PHARMA

ORCHID PHARMA
Cash Flow from Financing Activities

    Back to Cashflow Statement
AD     Remove this Ad

ORCHID PHARMA Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Financing Activities ₹25 Cr₹167 Cr₹31 Cr₹-217 Cr₹-165 Cr

What is the latest Cash Flow from Financing Activities ratio of ORCHID PHARMA ?

The latest Cash Flow from Financing Activities ratio of ORCHID PHARMA is ₹25 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Financing Activities
Mar2025₹25 Cr
Mar2024₹167 Cr
Mar2023₹31 Cr
Mar2022₹-217 Cr
Mar2021₹-165 Cr

How is Cash Flow from Financing Activities of ORCHID PHARMA Trending?

Years Cash Flow from Financing Activities % Change
Mar2025 ₹25 Cr
-84.90
Mar2024 ₹167 Cr
435.97
Mar2023 ₹31 Cr
Positive
Mar2022 ₹-217 Cr
Negative
Mar2021 ₹-165 Cr -

Compare Cash Flow from Financing Activities of peers of ORCHID PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ORCHID PHARMA ₹2,598.1 Cr 2.7% -25.6% -44.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹432,000.0 Cr -0.4% 5.3% 13.4% Stock Analytics
DIVIS LABORATORIES ₹161,076.0 Cr -4.3% -6.3% 12.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹148,510.0 Cr 0.4% 8.2% 44.7% Stock Analytics
DR REDDYS LABORATORIES ₹107,921.0 Cr 0.5% 1.8% 16.4% Stock Analytics
CIPLA ₹106,150.0 Cr -0.8% -2.6% -9.2% Stock Analytics


ORCHID PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
ORCHID PHARMA

2.7%

-25.6%

-44.4%

SENSEX

-5.5%

-11.5%

0.3%


You may also like the below Video Courses